著作和参考文献


Phase 2 clinical trial assessing vancomycin in patients with primary sclerosing cholangitis with/out inflammatory bowel disease

Cristoferi L, D’Amato D, Maino C, Bernasconi D, Dinelli ME, Malandrin SMI, Facciotti F, Festa MM, Gerussi A, Rossi E, Malinverno F, Tettamanti P, Cazzaniga ME, Corso R, Ippolito D, Galimberti S, Invernizzi P, Carbone M.

 BMJ Open. 2026 Jan 9;16(1):e106630. doi: 10.1136/bmjopen-2025-106630. PMID: 41513411; PMCID: PMC12815084.

2026
m30
肿瘤科
更多摘要

Exploration of Multiple Non-Invasive Tests for Assessing Response to Treatment in a Semaglutide Phase 2b Trial in Patients with MASH

Nitze LM, Ratziu V, Sanyal AJ, Wong VW, Balendran C, Fleckner J, Skalshøi Kjær M, Krarup N, Anstee QM.

Aliment Pharmacol Ther. 2026 Feb;63(3):396-404. doi: 10.1111/apt.70376. Epub 2025 Sep 23. PMID: 40985232; PMCID: PMC12807327.

2026
m30
肿瘤科
更多摘要

Blood metabolic panels for identifying significant fibrosis and inflammation in patients with MASLD

Huang Y, Li J, Song S, Du B, Cao Y, Wang Y, Fu H, Zhou T, Yu S, Liu Y, Wang K, Cao Z, Guo X, Xie C, Xie Q.

Cell Rep Med. 2026 Jan 20;7(1):102522. doi: 10.1016/j.xcrm.2025.102522. Epub 2025 Dec 19. PMID: 41421352; PMCID: PMC12866143.

2026
m30
肿瘤科
更多摘要

Severity of MASH Activity by Iron-Corrected MRI Predicts Insulin Resistance and Cardiometabolic Risk in Type 2 Diabetes

Ortiz Rocha A, Kalavalapalli S, Godinez Leiva E, Barb D, Bril F, Marangi SA, Thomaides-Brears HB, Rosenberg JT, Cuervo-Pardo N, Lomonaco R, Valdez Saenz E, Sharma A, Cusi K

J Clin Endocrinol Metab. 2026 Feb 11:dgag042. doi: 10.1210/clinem/dgag042. Epub ahead of print. PMID: 41669855.

2026
m30
肿瘤科
更多摘要

Effect of inulin supplementation on fecal and blood metabolome in alcohol use disorder patients: A randomised, controlled dietary intervention

Amadieu C, Ahmed H, Leclercq S, Koistinen V, Leyrolle Q, Stärkel P, Bindels LB, Layé S, Neyrinck AM, Kärkkäinen O, De Timary P, Hanhineva K, Delzenne NM.

Clin Nutr ESPEN. 2025 Apr;66:361-371. doi: 10.1016/j.clnesp.2025.01.046. Epub 2025 Jan 27. PMID: 39864520.

2025
m30
肿瘤科
更多摘要

Efficacy of Non-invasive Biomarkers in Diagnosing Non-alcoholic Fatty Liver Disease (NAFLD) and Predicting Disease Progression: A Systematic Review

Garg S, Varghese M, Shaik F, Jatin F, Sachdeva D, Wafa Eranhikkal F, Sahu S, Younas S.

 Cureus. 2025 Feb 3;17(2):e78421. doi: 10.7759/cureus.78421. PMID: 40046382; PMCID: PMC11881788.

2025
m30
肿瘤科
更多摘要

© 2016-2017 富士胶片和光(广州)贸易有限公司 网站建设合优网络